Evofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO June 30, 2022
Todos Medical Announces Positive Biomarker Data from Phase 2 Trial of Tollovir in Hospitalized COVID-19 Patients June 30, 2022
Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi® June 28, 2022